ZEISS and BOSELLO HIGH TECHNOLOGY (BOSELLO) announce that the Italian supplier of solutions for industrial X-ray systems, is now fully part of the ZEISS Group and will operate under the name Carl Zeiss X-ray Technologies Srl. In 2018, ZEISS acquired a majority stake in BOSELLO to strengthen ... more
Carl Zeiss Licences Digital Pathology from Olympus
Carl Zeiss Microscopy GmbH and Olympus America Inc. have signed a nonexclusive worldwide licensing agreement allowing Carl Zeiss to access an extensive portfolio of patents held by Olympus in the field of digital pathology and virtual microscopy. The patents included in the licensing deal cover methods and equipment for creating, storing and delivering virtual microscopy slides. The technology enables individuals to view and share high-resolution virtual microscopy images over the Internet.
"The handling of digital data has become a major driver of the development of modern microscopy,” said Dr. Bernhard Ohnesorge, Member of the Board and General Manager BioSciences Division of Carl Zeiss Microscopy. “Integrating the virtual slide functionality into our research microscope systems will enable our customers to become more efficient and to explore new scientific approaches. This will help them to better understand the root causes of the most challenging diseases.”
“Global adoption of digital slide scanning continues to expand into new medical and scientific applications,” said Brad Burklow, Executive Director Business Development, Scientific Equipment Group, Olympus Corporation of the Americas. “Olympus is the holder of many important patents in this area, and we feel it is vital to allow broad access to these technologies in order to advance the field of pathology and medical research. We are confident that leveraging these technologies will enhance healthcare for patients around the world.”
The companies are not making specific terms and conditions of the agreement public.
- Carl Zeiss
- virtual microscopy
ZEISS is expanding its imaging technology capabilities with 3D and big image data software by acquiring a majority stake in the imaging business of arivis. With this investment, ZEISS is further strengthening its software competencies and market position in 3D image visualization, image pro ... more
The ZEISS Group continued its growth trajectory, with revenue and earnings reaching new heights in fiscal year 2018/19, which ended 30 September 2019. Revenue grew by 11 percent, reaching 6.428 billion euros (previous year: 5.817 billion euros). Adjusted for currency and acquisition effects ... more
The National Research Council Canada (NRC) recently helped Olympus to design and commercialize a CARS (Coherent Anti-stokes Raman Scattering) microscope. The new Olympus microscope is based on a femtosecond non-linear optical process called CARS, which stands for Coherent Anti-Stokes Raman ... more
Olympus Microscopy has partnered with the Nature Publishing Group to present the Neurotechniques Collection. This compilation of articles will draw together some of the groundbreaking research that has recently been published in Nature Reviews Neuroscience and Nature Methods. Sponsored by O ... more
Olympus opened a new global Research and Development Centre for Life Science in Munich. Olympus will invest around EUR15m in this project and by 2009 it is expected that 450 people will be employed there. Dr Helmut Köhler, Executive Managing Director of both Olympus Life Science Europa GmbH ... more
The X-ray fluorescence spectrometer weighs only 1.7 kg and contains everything you need for X-ray fluorescence (XRF) analysis in lab quality more
High-Level Super Resolution ✓ Suited for Live Specimens ✓ Reveal Super Resolution Details Inside Your Samples more
The handheld Vanta X-ray fluorescence spectrometers let you analyze chemical compositions and identify alloys wherever you must. The compact X-ray fluorescence analyzers weigh only 1.7 kg and contain everything you need for X-ray fluorescence (XRF) analysis in lab quality.Typical applicatio ... more
Learn how modern deep learning-based approaches have the potential to reduce or replace fluorescence markers in live cell imaging. Use case included. more
- 1Detect neurodegenerative diseases such as Alzheimer's by a simple eye scan?
- 2Fluorescence microscopy at highest spatial and temporal resolution
- 3The Mechanics of the Immune System
- 4Resolve Biosciences Launches New Era in Single-Cell Spatial Analysis
- 5Quick look under the skin
- 6New ion trap to create the world's most accurate mass spectrometer
- 7How does your computer smell?
- 8Clocking electron movements inside an atom
- 9Sartorius closes 2020 with strong growth
- 10A clear path to better insights into biomolecules